- Naranj Research Desk
- 🇸🇦 Saudi Stock Market
- 🇺🇸 USA Stock Market
KRYS — NASDAQ —
Current RSI of this stock is 68.18, which indicates the strength of buyers.
Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
MACD line has crossed the signal line from the below, generates bullish signal.
Based on our swing trading strategies for USA stocks, Krystal Biotech stock price target will be USD 200 - USD 203 in the next 12-14 trading sessions.
Krystal Biotech, Inc. is a biotechnology company that focuses on discovering, developing, and commercializing genetic medicines for rare diseases in the United States. The company’s current focus is on commercializing VYJUVEK for the treatment of dystrophic epidermolysis bullosa, as well as developing several other genetic medicines for various rare diseases. Founded in 2016, Krystal Biotech, Inc. is based in Pittsburgh, Pennsylvania.
KRYS — NASDAQ —
Current RSI of this stock is 68.18, which indicates the strength of buyers.
Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
MACD line has crossed the signal line from the below, generates bullish signal.
Based on our swing trading strategies for USA stocks, Krystal Biotech stock price target will be USD 200 - USD 203 in the next 12-14 trading sessions.
Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.
Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.
Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.
If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website
